Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy
@article{Eisenberg2003PrevalenceAC,
title={Prevalence and Characteristics of Pain Induced by Percutaneous Liver Biopsy},
author={Elon Eisenberg and M Konopniki and E Veitsman and Rimma Kramskay and Diana Gaitini and Yaacov Baruch},
journal={Anesthesia \& Analgesia},
year={2003},
volume={96},
pages={1392-1396}
}Percutaneous needle liver biopsy is an important procedure for the diagnosis and evaluation of liver disease and is frequently associated with pain. In this prospective study, we investigated the prevalence and characteristics of this pain syndrome. Fifty-four subjects, who underwent liver biopsy under ultrasound guidance, received 5 mg of diazepam orally 1 h before the procedure and local infiltration with 10 mL of 2% lidocaine just before needle insertion. Outcome measures included the visual…
112 Citations
Pain During Percutaneous Liver Biopsy in Chronic Liver Disease Patients a Pilot Study
- Medicine
- 2010
The results of this pilot study suggest that, although deemed as minor, pain experienced during Percutaneous liver biopsy should be taken into consideration and that patients should be provided adequate prophylactic analgesia.
Need for analgesia after percutaneous liver biopsy: a real-life experience
- MedicineRadiologia brasileira
- 2021
Ultrasound-guided percutaneous liver biopsy is safe and well tolerated, and postprocedural pain does not correlate with the lobe punctured, patient age, or the indication for biopsy and appears to affect more women than men.
FREQUENCY OF PAIN ASSOCIATED WITH ULTRASOUND GUIDED PERCUTANEOUS LIVER BIOPSY
- Medicine
- 2012
Frequency of pain associated with ultrasound guided percutaneous trucut needle liver biopsy shows that females report pain more frequently than males, and the incidence of biopsy associated pain is more in patients who are addicted to narcotics.
Prophylactic analgesia before percutaneous liver biopsy: a clinical comparative study
- MedicineEuropean journal of gastroenterology & hepatology
- 2011
Prophylactic combination of short-acting tramadol and lorazepam is effective, safe, and can be used routinely before liver biopsy.
Liver Biopsy: Is the Pain for Real or is it Only the Fear of it?
- Medicine, PsychologyDigestive Diseases and Sciences
- 2006
The procedure of PLB is expected to be more painful than it really is by the patients, especially by females, and calming the patients by informing them about the procedure and their diseases will probably diminish the expected pain.
Pain after percutaneous liver biopsy for diffuse hepatic disease: a randomized trial comparing subcostal and intercostal approaches.
- MedicineJournal of vascular and interventional radiology : JVIR
- 2005
US-guided percutaneous liver biopsy performed with fentanyl and midazolam premedication is a well-tolerated procedure with minimal patient discomfort.
Pain and Anxiety Experienced by Patients Following Placement of a Percutaneous Endoscopic Gastrostomy.
- Medicine, PsychologyJPEN. Journal of parenteral and enteral nutrition
- 2015
It is likely that pain is not identified in patients unable to communicate and patients need to be better informed about the possibility of postprocedural pain and routinely offered access to appropriate analgesia.
Subcapsular local anesthesia approach in percutaneous liver biopsy: less pain, more comfort
- MedicineTurkish journal of medical sciences
- 2020
Subcapsular anesthesia is a well-tolerated procedure compared to a pericapsular procedure and the application of a subcapsular anesthetic with a subcostal approach was reported to result in the lowest pain and greatest patient comfort.
Ethnicity influences pain after ultrasound-guided percutaneous liver biopsy
- MedicineEuropean journal of gastroenterology & hepatology
- 2015
Ethnicity has an important role in the development of pain after US-guided percutaneous liver biopsy and has a significant impact on willingness to repeat the procedure.
Prospective investigation of pain associated with ultrasound- and computed tomography-guided percutaneous biopsies in oncological patients.
- Medicine, PsychologyMedical ultrasonography
- 2020
CT- and US- guided percutaneous biopsies are associated with low levels of pain that are generally well tolerated by patients irrespective of the targeted organ.
References
SHOWING 1-10 OF 33 REFERENCES
Midazolam sedation for percutaneous liver biopsy
- MedicineDigestive Diseases and Sciences
- 2005
It is concluded that there is no increased risk of percutaneous liver biopsy with midazolam and patients have less memory of the procedure with midAZolam.
Use of midazolam for percutaneous liver biopsy
- MedicineDigestive Diseases and Sciences
- 2005
Investigation of the ability of midazolam, a new water-soluble benzodiazepine preparation, noted for its potency, rapid onset of action, and amnestic qualities, to enhance patient acceptability of a follow-up liver biopsy suggests it reduces subject anxiety and perceived discomfort before and during PLB.
Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs.
- MedicineJournal of hepatology
- 1999
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
- MedicineHepatology
- 2000
Liver biopsy procedures vary greatly in France, hepatitis C is the main indication for liver biopsy at present, US‐guidance should be developed to reduce severe complications, and day‐care procedures increase acceptance of a future biopsy and should also be used more often.
Prediction and assessment of the severity of post-operative pain and of satisfaction with management
- MedicinePain
- 1998
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.
- MedicineJournal of hepatology
- 1986
Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: A randomized placebo-controlled trial
- MedicineAmerican Journal of Gastroenterology
- 2001
Patient-administered N2O/O2 inhalation provides safe and effective analgesia, at a reasonable cost, for PLB and could be useful for the management of patients with chronic liver disease undergoing PLB as it may enhance patients compliance with future biopsy.



